140 related articles for article (PubMed ID: 30456886)
1. Progression of hearing loss in neurofibromatosis type 2 according to genetic severity.
Emmanouil B; Houston R; May A; Ramsden JD; Hanemann CO; Halliday D; Parry A; Mackeith S
Laryngoscope; 2019 Apr; 129(4):974-980. PubMed ID: 30456886
[TBL] [Abstract][Full Text] [Related]
2. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
3. Progress of hearing loss in neurofibromatosis type 2: implications for future management.
Kontorinis G; Nichani J; Freeman SR; Rutherford SA; Mills S; King AT; Mawman D; Huson S; O'Driscoll M; Gareth Evans D; Lloyd SK
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3143-50. PubMed ID: 25294053
[TBL] [Abstract][Full Text] [Related]
4. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
6. Internal Auditory Canal Decompression for Hearing Maintenance in Neurofibromatosis Type 2 Patients.
Bernardeschi D; Peyre M; Collin M; Smail M; Sterkers O; Kalamarides M
Neurosurgery; 2016 Sep; 79(3):370-7. PubMed ID: 26579965
[TBL] [Abstract][Full Text] [Related]
7. Genetic Severity Score predicts clinical phenotype in NF2.
Halliday D; Emmanouil B; Pretorius P; MacKeith S; Painter S; Tomkins H; Evans DG; Parry A
J Med Genet; 2017 Oct; 54(10):657-664. PubMed ID: 28848060
[TBL] [Abstract][Full Text] [Related]
8. Audiologic Natural History of Small Volume Cochleovestibular Schwannomas in Neurofibromatosis Type 2.
deTorres AT; Brewer CC; Zalewski CK; King KA; Walker R; Scott GC; Asthagiri AR; Chittiboina P; Kim HJ
Otol Neurotol; 2018 Mar; 39(3):357-364. PubMed ID: 29342057
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
[TBL] [Abstract][Full Text] [Related]
11. Hearing changes after diagnosis in neurofibromatosis type 2.
Masuda A; Fisher LM; Oppenheimer ML; Iqbal Z; Slattery WH;
Otol Neurotol; 2004 Mar; 25(2):150-4. PubMed ID: 15021775
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
Sun S; Liu A
J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
[TBL] [Abstract][Full Text] [Related]
13. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
[TBL] [Abstract][Full Text] [Related]
14. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
15. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
[TBL] [Abstract][Full Text] [Related]
16. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
17. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
[TBL] [Abstract][Full Text] [Related]
18. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions.
Jacob JT; Carlson ML; Schiefer TK; Pollock BE; Driscoll CL; Link MJ
Neurosurgery; 2014 May; 74(5):466-74; discussion 474. PubMed ID: 24476904
[TBL] [Abstract][Full Text] [Related]
19. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
[TBL] [Abstract][Full Text] [Related]
20. Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2.
Dinh CT; Nisenbaum E; Chyou D; Misztal C; Yan D; Mittal R; Young J; Tekin M; Telischi F; Fernandez-Valle C; Liu XZ
Otol Neurotol; 2020 Jun; 41(5):e529-e537. PubMed ID: 32150022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]